Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.

CONCLUSION: Oral ER calcifediol is safe and effective in treating SHPT and vitamin D insufficiency in CKD.
PMID: 27676085 [PubMed - as supplied by publisher]

Source: American Journal of Nephrology - September 27, 2016 Category: Urology & Nephrology Authors: Sprague SM, Crawford PW, Melnick JZ, Strugnell SA, Ali S, Mangoo-Karim R, Lee S, Petkovich PM, Bishop CW Tags: Am J Nephrol Source Type: research